Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.
   PubMed Web of Science ®Google Scholar
• Patel MI, Cheng I, Gomez SL. US lung cancer trends by histologic type. Cancer. 2015;121:1150–1152.
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.
   PubMed Web of Science ®Google Scholar
• Li Y, Dong R, Lu M, et al. Let-7b-3p inhibits tumor growth and metastasis by targeting the BRF2-mediated MAPK/ERK pathway in human lung adenocarcinoma. Transl Lung Cancer Res. 2021;10:1841–1856.
   PubMed Web of Science ®Google Scholar
• Li G, Xie B, Li X, et al. Down-regulation of survivin and hypoxia-inducible factor-1 alpha by beta-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft. Cancer Biother Radiopharm. 2012;27:56–64.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Park S, Park H, et al. Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma. Cell. 2019;177:1842–1857.e21.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ma Y, Li Y, et al. Comparative analysis of co-occurring mutations of specific tumor suppressor genes in lung adenocarcinoma between Asian and Caucasian populations. J Cancer Res Clin Oncol. 2019;145:747–757.
   PubMed Web of Science ®Google Scholar
• Wang G, Bai X, Jiang G, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021;12:30–43.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Chen T, et al. alpha-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3beta/beta-catenin pathway. Bioengineered. 2021;12:5688–5704.
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu X, Zhang G, et al. Knockdown THOC2 suppresses the proliferation and invasion of melanoma. Bioengineered. 2019;10:635–645.
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen W, Gong Y, et al. Tetraspanin 1 (TSPAN1) promotes growth and transferation of breast cancer cells via mediating PI3K/Akt pathway. Bioengineered. 2021;12:10761–10770.
   PubMed Web of Science ®Google Scholar
• Young HJ, Lee JW, Kim S. Function of membranous lysyl-tRNA synthetase and its implication for tumorigenesis. Biochim Biophys Acta. 2016;1864:1707–1713.
   PubMed Web of Science ®Google Scholar
• Han JM, Kim JY, Kim S. Molecular network and functional implications of macromolecular tRNA synthetase complex. Biochem Biophys Res Commun. 2003;303:985–993.
   PubMed Web of Science ®Google Scholar
• Hyeon DY, Kim JH, Ahn TJ, et al. Evolution of the multi-tRNA synthetase complex and its role in cancer. J Biol Chem. 2019;294:5340–5351.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ruan ZR, Wang Y, et al. A threonyl-tRNA synthetase-like protein has tRNA aminoacylation and editing activities. Nucleic Acids Res. 2018;46:3643–3656.
   PubMed Web of Science ®Google Scholar
• Wellman TL, Eckenstein M, Wong C, et al. Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancer. BMC Cancer. 2014;14:620.
   PubMed Web of Science ®Google Scholar
• Jeong SJ, Kim JH, Lim BJ, et al. Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration. Exp Mol Med. 2018;50:e424.
   PubMed Web of Science ®Google Scholar
• Diodato D, Melchionda L, Haack TB, et al. VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Hum Mutat. 2014;35:983–989.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou XL, Ruan ZR, et al. A Human disease-causing point mutation in mitochondrial threonyl-tRNA synthetase induces both structural and functional defects. J Biol Chem. 2016;291:6507–6520.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zheng Y, Chen Z. Autophagy and mitochondrial encephalomyopathies. Adv Exp Med Biol. 2020;1207:103–110.
   PubMedGoogle Scholar
• Pang Y, Zhang Y, Zhang HY, et al. MUC13 promotes lung cancer development and progression by activating ERK signaling. Oncol Lett. 2022;23:37.
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhang X, Zhu H, et al. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2. Oncol Rep. 2021;45:523–534.
   PubMed Web of Science ®Google Scholar
• Zeng B, Ge C, Li R, et al. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Biomed Pharmacother. 2020;121:109562.
   PubMed Web of Science ®Google Scholar
• Zheng WQ, Pedersen SV, Thompson K, et al. Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease. Hum Mol Genet. 2021. DOI:10.1093/hmg/ddab257
   Web of Science ®Google Scholar
• Lee SH, Jaganath IB, Wang SM, et al. Antimetastatic effects of Phyllanthus on human lung (A549) and breast (MCF-7) cancer cell lines. PLOS ONE. 2011;6:e20994.
   PubMed Web of Science ®Google Scholar
• He TG, Xiao ZY, Xing YQ, et al. Tumor suppressor miR-184 enhances chemosensitivity by directly inhibiting SLC7A5 in retinoblastoma. Front Oncol. 2019;9:1163.
   PubMed Web of Science ®Google Scholar
• Chang H, Zou Z, Li J, et al. Photoactivation of mitochondrial reactive oxygen species-mediated Src and protein kinase C pathway enhances MHC class II-restricted T cell immunity to tumours. Cancer Lett. 2021;523:57–71.
   PubMed Web of Science ®Google Scholar
• Sivandzade F, Bhalerao A, Cucullo L. Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe. Biol Protoc. 2019;9. DOI:10.21769/BioProtoc.3128
   PubMed Web of Science ®Google Scholar
• Chazotte B. Labeling mitochondria with JC-1. Cold Spring Harb Protoc. 2011;2011(9). doi:10.1101/pdb.prot065490.
   Google Scholar
• Xu G, Fan L, Zhao S, et al. Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway. Bioengineered. 2021;12:1311–1323.
   PubMed Web of Science ®Google Scholar
• Jou MJ, Peng TI, Yu PZ, et al. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res. 2007;43:389–403.
   PubMed Web of Science ®Google Scholar
• Song C, Peng W, Yin S, et al. Melatonin improves age-induced fertility decline and attenuates ovarian mitochondrial oxidative stress in mice. Sci Rep. 2016;6:35165.
   PubMed Web of Science ®Google Scholar
• Pi H, Xu S, Reiter RJ, et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy. 2015;11:1037–1051.
   PubMed Web of Science ®Google Scholar
• Dong L, Yu L, Bai C, et al. USP27-mediated cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis. Oncogene. 2018;37:2702–2713.
   PubMed Web of Science ®Google Scholar
• Swaffer MP, Jones AW, Flynn HR, et al. CDK substrate phosphorylation and ordering the cell cycle. Cell. 2016;167:1750–1761.e16.
   PubMed Web of Science ®Google Scholar
• Ohtsubo M, Theodoras AM, Schumacher J, et al. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol. 1995;15:2612–2624.
   PubMed Web of Science ®Google Scholar
• Burkhart DL, Morel KL, Sheahan AV, et al. The role of RB in prostate cancer progression. Adv Exp Med Biol. 2019;1210:301–318.
   PubMed Web of Science ®Google Scholar
• Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016;42:63–71.
   PubMed Web of Science ®Google Scholar
• Teodoro JS, Palmeira CM, Rolo AP. Mitochondrial membrane potential (DeltaPsi) fluctuations associated with the metabolic states of mitochondria. Methods Mol Biol. 2018;1782:109–119.
   PubMedGoogle Scholar
• Zhu C, Zhang C, Cui X, et al. Trichosanthin inhibits cervical cancer by regulating oxidative stress-induced apoptosis. Bioengineered. 2021;12:2779–2790.
   PubMed Web of Science ®Google Scholar
• Lee CW, Chang KP, Chen YY, et al. Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness. Oncotarget. 2015;6:21979–21992.
   PubMedGoogle Scholar
• Kim EY, Jung JY, Kim A, et al. Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer. BMC Cancer. 2017;17:467.
   PubMed Web of Science ®Google Scholar
• Kwon NH, Kang T, Lee JY, et al. Dual role of methionyl-tRNA synthetase in the regulation of translation and tumor suppressor activity of aminoacyl-tRNA synthetase-interacting multifunctional protein-3. Proc Natl Acad Sci U S A. 2011;108:19635–19640.
   PubMed Web of Science ®Google Scholar
• Arita T, Morimoto M, Yamamoto Y, et al. Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation. Biochem Biophys Res Commun. 2017;488:648–654.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi JH, Wang P, et al. Mitochondrial threonyl-tRNA synthetase TARS2 is required for threonine-sensitive mTORC1 activation. Mol Cell. 2021;81:398–407.e4.
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926–1945.
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–348.
   PubMed Web of Science ®Google Scholar
• Kopecka J, Gazzano E, Castella B, et al. Mitochondrial metabolism: inducer or therapeutic target in tumor immune-resistance? Semin Cell Dev Biol. 2020;98:80–89.
   PubMed Web of Science ®Google Scholar
• Yan C, Duanmu X, Zeng L, et al. Mitochondrial DNA: distribution, mutations, and elimination. Cells. 2019;8:379.
   PubMed Web of Science ®Google Scholar
• Kampjut D, Sazanov LA, Mencarini L. The coupling mechanism of mammalian respiratory complex I. Science. 2020;369(6502):370.
   PubMedGoogle Scholar
• Hagen CM, Aidt FH, Havndrup O, et al. MT-CYB mutations in hypertrophic cardiomyopathy. Mol Genet Genomic Med. 2013;1:54–65.
   PubMedGoogle Scholar
• Errichiello E, Balsamo A, Cerni M, et al. Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis. J Mol Med (Berl). 2015;93:1271–1281.
   PubMed Web of Science ®Google Scholar
• Lubośny M, Przyłucka A, Śmietanka B, et al. Actively transcribed and expressed atp8 gene in Mytilus edulis mussels. PeerJ. 2018;6:e4897.
   PubMed Web of Science ®Google Scholar
• Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria as targets for chemotherapy. Apoptosis. 2009;14:624–640.
   PubMed Web of Science ®Google Scholar
• Ott M, Gogvadze V, Orrenius S, et al. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12:913–922.
   PubMed Web of Science ®Google Scholar
• Kim WS, Lee KS, Kim JH, et al. The caspase-8/Bid/cytochrome c axis links signals from death receptors to mitochondrial reactive oxygen species production. Free Radic Biol Med. 2017;112:567–577.
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Koshikawa N, Takenaga K, et al. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion. 2008;8:339–344.
   PubMed Web of Science ®Google Scholar
• Gonzalo R, Garcia-Arumi E, Llige D, et al. Free radicals-mediated damage in transmitochondrial cells harboring the T14487C mutation in the ND6 gene of mtDNA. FEBS Lett. 2005;579:6909–6913.
   PubMed Web of Science ®Google Scholar
• Dos Santos JM, de Oliveira DS, Moreli ML, et al. The role of mitochondrial DNA damage at skeletal muscle oxidative stress on the development of type 2 diabetes. Mol Cell Biochem. 2018;449:251–255.
   PubMed Web of Science ®Google Scholar
• Madsen-Bouterse SA, Mohammad G, Kanwar M, et al. Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. Antioxid Redox Signal. 2010;13:797–805.
   PubMed Web of Science ®Google Scholar
• Weiss H, Wester-Rosenloef L, Koch C, et al. The mitochondrial Atp8 mutation induces mitochondrial ROS generation, secretory dysfunction, and beta-cell mass adaptation in conplastic B6-mtFVB mice. Endocrinology. 2012;153:4666–4676.
   PubMed Web of Science ®Google Scholar
• Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.
   PubMed Web of Science ®Google Scholar
• Estaquier J, Vallette F, Vayssiere JL, et al. The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012;942:157–183.
   PubMed Web of Science ®Google Scholar
• Lopez J, Tait SW. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer. 2015;112:957–962.
   PubMed Web of Science ®Google Scholar
• Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21:85–100.
   PubMed Web of Science ®Google Scholar
• Nishi K, Iwaihara Y, Tsunoda T, et al. ROS-induced cleavage of NHLRC2 by caspase-8 leads to apoptotic cell death in the HCT116 human colon cancer cell line. Cell Death Dis. 2017;8:3218.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhao G, Zhu X, et al. Sodium selenite induces apoptosis via ROS-mediated NF-kappaB signaling and activation of the Bax-caspase-9-caspase-3 axis in 4T1 cells. J Cell Physiol. 2019;234:2511–2522.
   PubMed Web of Science ®Google Scholar
• Tripathi SK, Rengasamy KRR, Biswal BK. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction. Arch Pharm Res. 2020;43:242–256.
   PubMed Web of Science ®Google Scholar
• Kim JY, Park JH. ROS-dependent caspase-9 activation in hypoxic cell death. FEBS Lett. 2003;549:94–98.
   PubMed Web of Science ®Google Scholar
• Dubey M, Nagarkoti S, Awasthi D, et al. Nitric oxide-mediated apoptosis of neutrophils through caspase-8 and caspase-3-dependent mechanism. Cell Death Dis. 2016;7:e2348.
   PubMed Web of Science ®Google Scholar
• Zhivotovsky B. Caspases: the enzymes of death. Essays Biochem. 2003;39:25–40.
   PubMed Web of Science ®Google Scholar